Capital Change Notice

Capital Change Notice




Section 1: Issuer information
Name of issuer Rua Bioscience Limited
NZX ticker code RUA
Class of financial product Ordinary shares
ISIN (If unknown, check on NZX website) NZRUAE0004S1
Currency NZ$
Section 2: Capital change details
Number issued/acquired/redeemed 666,667 ordinary shares
Nominal value (if any) N/A
Issue/acquisition/redemption price per security $0.03
Nature of the payment (for example, cash or other
consideration)
Cash
Amount paid up (if not in full) Paid in full

Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of
Financial Products of the Class, excluding any Treasury Stock,
in existence)
1

Rua currently has 238,448,011
ordinary shares on issue and
5,423,465 warrants on issue.
This issue of ordinary shares
represents 0.27% of the total
ordinary shares plus warrants
on issue (being the percentage
should all warrants vest and be
exercised).
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion
price and Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial Product) or the
Option (for example, the exercise price and exercise date)
N/A
Reason for issue/acquisition/redemption and specific authority
for issue/acquisition/redemption/ (the reason for change must
be identified here)
Placement of new ordinary
shares to fund short-term
working capital requirements
and authorised by a Board
resolution on 9th September
2025.
Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding Treasury
Stock) and the total number of Financial Products of the Class
held as Treasury Stock after the issue/acquisition/redemption.
Total ordinary shares on issue:
239,114,678 ordinary shares
Total warrants on issue:
5,423,465 warrants
In the case of an acquisition of shares, whether those shares
are to be held as treasury stock
N/A

1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Specific authority for the issue, acquisition, or redemption,
including a reference to the rule pursuant to which the issue,
acquisition, or redemption is made
Board resolution and Listing
Rule 4.5.1
Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
Issue of ordinary shares which
rank equally with all other fully
paid ordinary shares
Date of issue/acquisition/redemption 10/9/2025
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this announcement Paul Naske
Contact person for this announcement Paul Naske
Contact phone number 021 445 154
Contact email address Paul.naske@ruabio.com
Date of release through MAP

11/09/2025